<DOC>
	<DOC>NCT01433107</DOC>
	<brief_summary>This study will compare the efficacy and safety of a single dose of terbinafine film forming solution 1% with a single dose of placebo film forming solution in the treatment of tinea pedis.</brief_summary>
	<brief_title>Efficacy and Safety of Terbinafine Film Forming Solution in Patients With Tinea Pedis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Terbinafine</mesh_term>
	<criteria>Patients â‰¥18 years of age with interdigital tinea pedis infection, with clinical diagnosis meeting required baseline total sign &amp; symptom score and positive microscopy Allergy to the allylamine class of antimycotics or excipients in the formulation. Chronic, hyperkeratotic plantar (moccasin) tinea pedis Other fungal disease or intertrigo Other abnormal findings on the affected foot Systemic antifungal or antimicrobial treatment within the last 3 months Topical treatment for skin lesions on feet within the last 3 months Diabetes mellitus and peripheral artery occlusive disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Tinea pedis</keyword>
	<keyword>Terbinafine film forming solution</keyword>
</DOC>